Bormel says “DTE remains available.” But how?
This week's DTE discussion with FDA made some progress, but there's more work to be done by compounders.
Registration opens for “Best Practices” Conference
Register by January 4, 2023 for early bird pricing.
Hey PFMs: Stick it!
We recently sent our Pharmacy/Facility Members a magnet with a message to "stick it!"
Chapter <797> includes BUD, batch size restrictions
The revised USP Chapter <797> related to sterile compounding, released on Tuesday, includes restrictions on beyond-use dates and batch size for CSPs that APC and others had argued were not supported by scientific evidence.
A confusing proposed rule in Delaware
A proposed rule by the Delaware Board of Pharmacy has the potential to limit office stock compounding for veterinarians by 503A pharmacies. APC is submitting a comment letter and will be attending the board meeting on November 16.
Share this: The PCF scholarship application is now open
The Pharmacy Compounding Foundation (PCF) will award up to two $2,500 scholarships in 2023 to pharmacy students who have demonstrated commitment to a career in compounding pharmacy in the US.
It takes a lot of money to make nothing happen.
It has been two years since we started talking about FDA’s implicit threat to restrict compounded hormones. So far, the agency has done nothing.